Previous Close | 2,826.35 |
Open | 2,845.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 2,795.10 - 2,854.20 |
52 Week Range | 2,137.55 - 3,145.00 |
Volume | |
Avg. Volume | 182,804 |
Market Cap | 87.436B |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | 23.90 |
EPS (TTM) | 118.42 |
Earnings Date | Jan 16, 2025 - Jan 20, 2025 |
Forward Dividend & Yield | 19.00 (0.67%) |
Ex-Dividend Date | Sep 18, 2024 |
1y Target Est | 3,094.00 |
The partners aim to promote the implementation of FHIR standards and improve patient outcomes by improving data sharing.
As global markets continue to recover from the early August sell-off, hopes for a "soft landing" in the U.S. economy have buoyed investor sentiment. The S&P 600, which tracks small-cap stocks, has also seen gains amid this positive outlook. In such an environment, identifying undervalued small-cap stocks with significant insider action can offer promising opportunities for investors looking to capitalize on market momentum and potential growth.